Drug class
Glucocorticosteroids (non-oral and non-injectables)
The phrase "Glucocorticosteroids (non-oral and non-injectables)" is an administrative classification based on route of administration rather than an official standalone pharmacological drug class. Read more about Glucocorticosteroids (non-oral and non-injectables)
50 drugs in this class 30 manufacturers
Drugs in Glucocorticosteroids (non-oral and non-injectables)
ANUSOL-HC (hydrocortisone acetate)
PROCTOCORT (hydrocortisone)
UCERIS (budesonide)
HYDROCORTISONE ACETATE
The phrase "Glucocorticosteroids (non-oral and non-injectables)" is an administrative classification based on route of administration rather than an official standalone pharmacological drug class.
It encompasses topical, inhaled, intranasal, ophthalmic, and rectal formulations of glucocorticoids designed to deliver localized anti-inflammatory and immunosuppressive therapy while minimizing systemic absorption and toxicity.
These agents bind to intracellular glucocorticoid receptors to inhibit pro-inflammatory cytokines and alter gene transcription, making them essential in managing localized disorders such as asthma, allergic rhinitis, inflammatory dermatoses, ocular inflammation, and distal ulcerative colitis.
-
nih.gov
The phrase "Glucocorticosteroids (non-oral and non-injectables)" is an administrative classification based on route of administration rather than an official standalone pharmacological drug class It encompasses topical, inhaled, intranasal, ophthalmic, and rectal formulations of glucocorticoids designed to deliver localized anti-inflammatory and immunosuppressive therapy while minimizing systemic absorption and toxicity
-
nhsinform.scot
The phrase "Glucocorticosteroids (non-oral and non-injectables)" is an administrative classification based on route of administration rather than an official standalone pharmacological drug class It encompasses topical, inhaled, intranasal, ophthalmic, and rectal formulations of glucocorticoids designed to deliver localized anti-inflammatory and immunosuppressive therapy while minimizing systemic absorption and toxicity These agents bind to intracellular glucocorticoid receptors to inhibit pro-i...
-
arthritis.org
It encompasses topical, inhaled, intranasal, ophthalmic, and rectal formulations of glucocorticoids designed to deliver localized anti-inflammatory and immunosuppressive therapy while minimizing systemic absorption and toxicity These agents bind to intracellular glucocorticoid receptors to inhibit pro-inflammatory cytokines and alter gene transcription, making them essential in managing localized disorders such as asthma, allergic rhinitis, inflammatory dermatoses, ocular inflammation, and dista...
-
drugs.com
These agents bind to intracellular glucocorticoid receptors to inhibit pro-inflammatory cytokines and alter gene transcription, making them essential in managing localized disorders such as asthma, allergic rhinitis, inflammatory dermatoses, ocular inflammation, and distal ulcerative colitis
-
healthline.com
These agents bind to intracellular glucocorticoid receptors to inhibit pro-inflammatory cytokines and alter gene transcription, making them essential in managing localized disorders such as asthma, allergic rhinitis, inflammatory dermatoses, ocular inflammation, and distal ulcerative colitis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.